Genome Editing

Genome editing with engineered nucleases (GEEN) is emergent type of Genetic Engineering. GEEN is the technology in which DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level. Genome Editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or mega nucleases.

  • Stem cell and cellular therapies
  • Cell therapy: clinical trials
  • Paediatrics’ and Genetics
  • Market and Future Prospects of Gene Therapy
  • Gene Editing and CRISPR Based Technologies
  • meganucleases
  • Gene targeting


 


    Related Conference of Genome Editing

    October 17-18, 2022

    21st International Conference on Structural Biology

    Barcelona, Spain
    November 15-16, 2022

    3rd Experts Meeting on Plant, Cellular and Molecular Biology

    Budapest, Hungary
    November 21-22, 2022

    4th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada
    May 03-04, 2023

    16th World Congress on Stem Cell Research

    Paris, France
    May 03-04, 2023

    Global Conference on Cell and Gene Therapy

    Paris, France

    Genome Editing Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in